Mar 13, 2017 20:05 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., March 13, 2017 -- Global Blood Therapeutics, Inc.(GBT) (NASDAQ:GBT) today reported business progress and financial results for the fourth quarter and year ended December 31, 2016. "2016...
Retail Opportunity Investments Corp. Schedules First Quarter Earnings Release and Conference Call
Mar 13, 2017 20:05 pm UTC| Business
SAN DIEGO, March 13, 2017 -- Retail Opportunity Investments Corp. (NASDAQ:ROIC) will issue financial and operational results for the first quarter ended March 31, 2017 after the market closes on Wednesday, April 26,...
Pacira Pharmaceuticals, Inc. to Present at the Barclays Global Healthcare Conference
Mar 13, 2017 20:02 pm UTC| Business
PARSIPPANY, N.J., March 13, 2017 -- Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) today announced that its management team is scheduled to present at the Barclays Global Healthcare Conference at 10:15 a.m. ET on Thursday,...
Anthera Pharmaceuticals Announces Proposed Public Offering of Common Stock and Warrants
Mar 13, 2017 20:01 pm UTC| Business
HAYWARD, Calif., March 13, 2017 -- Anthera Pharmaceuticals, Inc.(Nasdaq:ANTH) (the “Company”)today announced that it intends to offer and sell shares of its common stock and warrants to purchase shares of its common...
Mar 13, 2017 20:01 pm UTC| Business
REDWOOD CITY, Calif., March 13, 2017 -- Coherus BioSciences, Inc. (Nasdaq:CHRS), today reviewed corporate events and reported financial results for the fourth quarter and full year 2016. Corporate Highlights for the...
Cascadian Therapeutics Announces Changes to Board of Directors
Mar 13, 2017 20:01 pm UTC| Business
SEATTLE, March 13, 2017 -- Cascadian Therapeutics, Inc. (NASDAQ:CASC), a clinical-stage biopharmaceutical company, today announced that Robert W. Azelby has been appointed to the Company’s Board of Directors. Mr. Azelby...
RedHawk Announces Second Quarter Results
Mar 13, 2017 20:00 pm UTC| Business
YOUNGSVILLE, La., March 13, 2017 -- RedHawk Holdings Corp. (OTCQB:IDNG) (“RedHawk” or the “Company”) announced today a consolidated net loss of $282,027 ($nil per share) on gross revenues of $718,337 for the three month...